eFFECTOR Therapeutics, Inc.
EFTR · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $25,565 | $17,608 | $334,429 | $148,892 |
| - Cash | $14,875 | $8,708 | $49,702 | $15,216 |
| + Debt | $20,545 | $20,281 | $20,030 | $12,961 |
| Enterprise Value | $31,235 | $29,181 | $304,757 | $146,637 |
| Revenue | $0 | $3,553 | $1,430 | $42,000 |
| % Growth | -100% | 148.5% | -96.6% | – |
| Gross Profit | -$111 | $3,500 | $1,406 | $42,000 |
| % Margin | – | 98.5% | 98.3% | 100% |
| EBITDA | -$32,781 | -$20,361 | $17,586 | $16,055 |
| % Margin | – | -573.1% | 1,229.8% | 38.2% |
| Net Income | -$35,811 | -$12,927 | $15,798 | $14,211 |
| % Margin | – | -363.8% | 1,104.8% | 33.8% |
| EPS Diluted | -16.37 | -7.85 | 9.78 | 0.1 |
| % Growth | -108.5% | -180.3% | 9,680% | – |
| Operating Cash Flow | -$29,550 | -$25,899 | -$24,888 | $13,835 |
| Capital Expenditures | -$97 | -$192 | -$42 | -$154 |
| Free Cash Flow | -$29,647 | -$26,091 | -$24,930 | $13,681 |